News Headlines Article

Oregon grapples with cost of Gilead’s $1,000-a-pill hepatitis C drug
San Francisco Business Times

Oregon legislators grappled Monday with the enormous cost of curing hepatitis C patients covered by the Oregon Health Plan. It could cost as much as $480 million to attempt to cure all hepatitis C patients covered by the state’s Medicaid program, state health officials testified Monday afternoon before state legislators. “The issue is, do we spend money on this or do we spend the money some other way?” said committee chair Rep. Mitch Greenlick, D-Portland.